Strategic Partners A/S
The answer first
Does Strategic Partners beat the market?
No, Strategic Partners has not beaten the market over the last year.
The ranking · Quality, value and trend combined
Better than 45% of Nordic stocks
- Quality88
- Value42
- Trend19
No. 67 of 195 in healthcare
Expectations in the price
Moderate expectations
For the share to return about 9% a year from today's price, the cash Strategic Partners keeps must grow about 6% a year for 10 years.
Max for seven days
Follow Strategic Partners with AuroraAurora lets you know at the next report. No card.
Both with dividends. Figures as of 17 November 2026. General analysis, not personal advice.
Follow your thesis
Ask Aurora about Strategic Partners
Your first answer is free, no account needed.
Do you own Strategic Partners, or are you thinking about it?
See it next to the rest of your portfolio, or build your first one with Strategic Partners and a few more. Free, no card.
Super Stock+45.1%In short
- Strategic Partners has fallen 29.1% over the past year, including dividends.
- Overall, Strategic Partners ranks better than 45% of Nordic stocks on quality, value and trend.
- The largest fall over the past three years was 99.3%. The price is 99.6% below its peak now.
Quality, value and trend
Quality is about the company, value about the price you pay, and trend about the share price. Each pillar shows the numbers it is built on.
Quality, value and trend together. Better than 45% of Nordic stocks.
No. 67 of 195 in healthcare
High A solid company: it earns well on its money and has healthy finances.
No. 39 of 196 in healthcareTypical in healthcare: 64Typical in the Nordics: 50
- Debt to equityBorrowings divided by equity1.73
- Asset turnoverSales divided by everything the company owns0.02
- Return on equityProfit divided by equity+6.9%
- Cash conversionOperating cash flow divided by profit0.86
The ranking is built on equity ratio, ROA and how steadily profit grows.
Medium Fair price: about the same as a typical Nordic stock.
No. 58 of 197 in healthcareTypical in healthcare: 20Typical in the Nordics: 50
- P/BPrice divided by equity1.2
- P/SPrice divided by sales56.0
- P/EPrice divided by earnings17.0
- P/CFPrice divided by operating cash flow19.9
The ranking is built on P/E, P/B and P/S.
Low Headwind in the share price: it has done worse than most over the last year.
No. 130 of 198 in healthcareTypical in healthcare: 34Typical in the Nordics: 50
- 3 months−16.8%
- 6 months−11.8%
- 9 months−16.2%
- 12 months−29.1%
The ranking is built on 3, 6 and 12–1 months.
Return and risk
Return with dividends reinvested.
The funds that own Strategic Partners
4 funds we follow own Strategic Partners. The share is how much of the fund the stock makes up.
- Denmark4
From the funds' latest known holdings.
About Strategic Partners
Strategic Partners A/S is a company in healthcare, listed on Nasdaq Copenhagen. The share trades in DKK. It has around 1 employees.
Strategic Partners A/S does not have significant operations. Previously, it was engaged in biotech activities. The company was formerly known as Orphazyme A/S and changed its name to Strategic Partners A/S in October 2024. Strategic Partners A/S was incorporated in 2009 and is based in Herlev, Denmark.


See the full analysis of Strategic Partners.
The accounts, dividends, 40 years of charts and the comparison with other stocks are in the app.
Free forever · No card